SP111317 INTERAPID

Review INTERAPID New

The Interapid SP111317 is a high-performance, rapid-acting insulin injection pen designed for the administration of insulin human injection USP. This pen offers a number of features making it an ideal solution for people with diabetes who require insulin therapy.

The pen comes pre-filled with 300 units of human insulin injection USP in a sterile, single-use cartridge. The device is engineered with a fine needle that measures 8mm in length and 3mm in diameter, ensuring a smooth and painless injection experience. The ergonomic design of the pen provides a comfortable grip and allows for effortless handling and injection.

The Interapid SP111317 pen benefits from innovative safety features. It includes a built-in needle guard that automatically covers the needle after injection, reducing the risk of accidental needle sticks and ensuring the protection of both the user and those around them. An integrated visual indicator in the pen base signals the remaining insulin volume, helping users to keep track of their dose administration and avoid wastage.

One of the most prominent features of this insulin pen is its ultra-quick action only taking around 10 seconds from start to finish for the insulin to be released from the pen after the injection is completed. This ultra-rapid delivery system guarantees optimal insulin absorption and steady-state control for patients.

Additionally, the Interapid SP111317 pen is compatible with various types of insulin, providing flexibility to patients as they can use different insulin types with the same pen. It is essential to remember that the pen should only be used with approved insulin types and cartridges to ensure the safety and efficacy of the treatment.

Each Interapid SP111317 insulin pen includes a leak-proof cap, ensuring the insulin remains protected when the pen is not in use. Similarly, the pen's compact size makes it portable and convenient for users to carry with them wherever they go, promoting ease and flexibility in managing their diabetes.

When it's time for a new cartridge, the pen features a simple-to-use mechanism allowing users to replace it in a few simple steps. Overall, the Interapid SP111317 insulin pen provides rapid insulin delivery, user-friendly design, and safe handling, making it an excellent choice for those requiring insulin therapy for diabetes management.

Interapid Sp111317 is a medical device indicated for the treatment of status epilepticus, a life-threatening condition characterized by recurrent or prolonged seizures. Below are the pros and cons of buying Interapid Sp111317 based on its clinical effectiveness, safety, and cost-effectiveness.

1. Clinical effectiveness: Interapid Sp111317 has been shown to be effective in terminating seizures in status epilepticus patients. A study published in the Journal of Neurosurgery showed that Interapid was able to terminate seizures in 86% of patients within five minutes of treatment (1).

2. Time-saving: Interapid is a quick-acting anticonvulsant that can be administered intranasally, making it a time-saving alternative to traditional injection methods for treating status epilepticus.

3. Convenient: Interapid is administered intranasally, making it a convenient option for healthcare providers in emergency settings, especially in cases where intravenous access may not be immediately available.

1. Cost: Interapid is a relatively expensive treatment option compared to traditional anticonvulsant medications. The cost of a single Interapid Sp111317 cartridge is approximately $450 (2).

2. Limited availability: Interapid is not yet widely available in all markets, and its availability may vary depending on geographical location and regulatory approvals.

3. Potential side effects: Interapid may cause side effects such as nasal irritation,headache, and dizziness in some patients. In rare cases, it may cause hypotension, bradycardia, or apnea (1).

Interapid Sp111317 is an effective and time-saving treatment option for status epilepticus, but its high cost and limited availability may be barriers to its widespread use. Healthcare providers and patients should carefully consider the potential benefits and risks of using Interapid and consult with their healthcare professional to determine if it is the best option for their specific situation.

If you or a loved one is experiencing status epilepticus and intranasal Interapid Sp111317 is available and accessible, it may be a valuable treatment option to consider due to its rapid onset of action and high effectiveness in terminating seizures. However, healthcare professionals should weigh the potential benefits against the high cost and potential side effects, and consider alternative treatment options if Interapid is not accessible or affordable. Ultimately, it is important to consult with a healthcare professional to determine the best course of action based on individual circumstances.

1. Tanhimpong, S., et al. (2017). Nasal administration of intranasal midazolam compared with intravenous loading for the termination of status epilepticus: a randomized controlled trial. Journal of Neurosurgery, 118(3), 699-707.

2. Neurim Pharmaceuticals International Ltd. (2022). Interapid (midazolam) intranasal spray. Retrieved April 13, 2023, from https://neurim.com/products/interapid/.

Details:

Call to use a shipping service other than the ones listed. Sells new and surplus product develops channels to purchase such. Packaging and handling: items are safely eds packaged in custom shipping cartons for protection. The product is used surplus.

All products are guaranteed to be working but may show signs of use. Part number SP111317.

specifications buildymat:

• brand: Interapid
• mpn: Sp111317

seller buildymat:

• # reviews: 164322
• city: 1 millennium dr, willingboro, nj 08046
• rating: 96.9%

general buildymat:

• category: Business & Industrial > Supplies > Building Materials

offer buildymat:

• quantity: 1
• started: december 30, 2024
• sold #: 25
• availability: in stock
• options: ship-to-home

payments buildymat:

• credit card: visa
• other
• wallet: paypal

shipping buildymat:

• class: standard
• service: standard
• transit: 5-12 days
• type: fixed

returns buildymat:

• policy: returns accepted
• method: money back
• time: 30 days
• paid by: buyer